Bright Minds Biosciences, Inc. (DRUG)
52.43
+0.43
(+0.83%)
USD |
NASDAQ |
Oct 08, 16:00
52.00
-0.43
(-0.82%)
After-Hours: 20:00
Bright Minds Biosciences Net Income (Quarterly) : -1.732M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.732M |
| March 31, 2026 | -7.625M |
| December 31, 2025 | -5.426M |
| September 30, 2025 | -2.967M |
| June 30, 2025 | -3.786M |
| March 31, 2025 | -2.056M |
| December 31, 2024 | 0.0355M |
| September 30, 2024 | -0.5671M |
| June 30, 2024 | 0.168M |
| March 31, 2024 | -0.4257M |
| December 31, 2023 | -1.237M |
| September 30, 2023 | -1.139M |
| June 30, 2023 | -1.086M |
| Date | Value |
|---|---|
| March 31, 2023 | -1.516M |
| December 31, 2022 | -1.720M |
| September 30, 2022 | -2.267M |
| June 30, 2022 | -2.082M |
| March 31, 2022 | -3.543M |
| December 31, 2021 | -3.854M |
| September 30, 2021 | -2.275M |
| June 30, 2021 | -2.878M |
| March 31, 2021 | -1.250M |
| December 31, 2020 | -0.5782M |
| March 31, 2020 | -0.0046M |
| December 31, 2019 | -0.0238M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Amgen, Inc. | 2.375B |
| Lineage Cell Therapeutics, Inc. | 1.544M |
| Recursion Pharmaceuticals, Inc. | -131.00M |
| Agenus, Inc. | -0.567M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.732M |
| EPS Diluted (Quarterly) | -0.1762 |
| Enterprise Value | 296.01M |
| Earnings Yield | -3.98% |
| Normalized Earnings Yield | -3.975 |